CERo Therapeutics Holdings, Inc.CERo Therapeutics Holdings, Inc.CERo Therapeutics Holdings, Inc.

CERo Therapeutics Holdings, Inc.

No trades
See on Supercharts

CERO fundamentals

An in-depth look to CERo Therapeutics Holdings, Inc. operating, investing, and financing activities

CERO free cash flow for Q3 24 is -2.76 M USD. For 2023, CERO free cash flow was -1.52 M USD and operating cash flow was -1.52 M USD.

Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪0.00‬
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
TTM
Free cash flowYoY growth